Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder
Sponsor: Alkermes, Inc.
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of ALKS 7290 following oral administration in adult participants with Major Depressive Disorder.
Official title: A Phase 2, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2026-10
Completion Date
2028-01
Last Updated
2026-10-28
Healthy Volunteers
No
Conditions
Interventions
ALKS 7290 Dose
Daily oral ALKS 7290 with antidepressant therapy
Placebo
Daily oral placebo with antidepressant therapy
Locations (1)
Alkermes Investigator Site
Jacksonville, Florida, United States